|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/54 | |
| A61P 25/24 | |||
| C07D 495/04 |
| (11) | Number of the document | 2790734 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12829183.8 |
| Date of filing the European patent application | 2012-12-14 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/002992 |
| Date | 2012-12-14 |
| (87) | Number | WO 2013/088255 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| 201161576244 P | 2011-12-15 | US |
| (72) |
BLUMBERG, Laura, Cook, US
LOWE, John, Adam, US
ALMARSSON, Orn, US
ALVAREZ, Juan, US
ZEIDAN, Tarek, A., US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (54) | PRODRUGS OF SECONDARY AMINE COMPOUNDS |
| PRODRUGS OF SECONDARY AMINE COMPOUNDS |